The global blood collection market size was estimated at USD 10.64 billion in 2022 and is expected to grow at a compound annual growth (CAGR) of 8.2% of 2023 to 2030. The market growth is being driven by several key factors, including the growing incidence of infectious diseases, a rise in accident & trauma cases, and the increasing prevalence of non-communicable diseases. According to the World Health Organization 2022 statistics, each year approximately 41 million mortality cases occur due to non-communicable diseases, accounting for 74% of all deaths worldwide. In addition, nearly 77% of these deaths happen in middle- and low-income countries. Blood collection products are used to treat patients suffering from chronic diseases, particularly during complex surgeries, dialysis, chemotherapy, and tissue or organ transplantation procedures.
These products are also used during the diagnosis of various infectious and non-infectious diseases. Therefore, the increased incidence of infectious and non-communicable diseases has created a huge demand for such products, which led to the growth of the market.Furthermore, government initiatives to reduce the incidence rate of non-communicable diseases contributed to the demand for blood collection. For instance, in February 2022, VA collaborated with the American Red Cross as well as America's Blood Centers' regional blood collection organizations to initiate its comprehensive network of healthcare facilities to promote the country's need for blood. Such initiatives support market growth.The growing number of casualties and trauma cases on a global scale is another key factor driving the marketgrowth.
Blood collection products play a crucial role in providing necessary treatment for patients affected by trauma or accidents. For instance, as per the WHO, 1.35 million deaths occurred worldwide in road accidents in 2022, with 20-50 million suffering non-fatal injuries. Thus, the United Nations General Assembly has created an ambitious goal of reducing the worldwide number of fatalities and injuries caused by road traffic crashes by 50% by the year 2030. The global pandemic had a strong impact on the market. During the pandemic, there have been disruptions in blood donations due to various factors. Lockdowns, social distancing measures, and fear of infection have led to a decrease in the number of donors, resulting in a shortage of blood supply.
According to a report by the Association for the Advancement of Blood & Biotherapies in Japan, the onset of the pandemic led to a significant and rapid decline in donors, with a 21% decrease at the start of the pandemic. This necessitated urgent efforts to mobilize donors. In addition, blood centers faced various challenges during the pandemic, including recruiting healthy donors, ensuring the safety of staff, donors, and patients, as well as managing inventory effectively.Moreover, many government agencies have taken measures to improve donation rates in response to the blood shortage experienced during the pandemic. For instance, the Maharashtra state government implemented social media action plans in June 2020 to increase the number of blood donations. These initiatives had a notable impact on the global market during the pandemic.
Based on the collection site, the market is segmented into venous and capillary. The venous segment dominated the market in 2022 and accounted for the largest revenue share of 82.89%. The increase in demand for detection and diagnosis medical equipment, as well as arise in the number of surgical procedures, are the main factors driving the growth of the segment.Furthermore, growing awareness regarding the advantages of venous blood collection devices compared to alternative methods is driving the expansion of the market. The key benefit of these devices is their comparatively painless nature, requiring only a small blood sample for the procedure. This is anticipated to contribute to the market's growth.
The capillary segment is anticipated to witness the fastest growth rate during the forecast period owing to factors, such reduced number of blood samples required, which minimizes the risk of contamination. In addition, key companies are investing more in research and development to create a wide range of innovative products and the emergence of innovation for automated hematology analyzers is contributing to the market's growth. Moreover, collaborations and partnerships among key players also contribute to the market's growth. An example of such collaboration is the partnership between Q-Sera Pty. Ltd. and Terumo Corp. announced in November 2021. Under this partnership, Terumo Corporation obtained exclusive rights to manufacture and sell the company’s RAPClot rapid serum blood collection tube technology in Japan. This partnership enhances the availability of products in the market, thereby fueling overall market growth.
Based on applications, the market is segmented into treatment and diagnostics. The diagnostics segment dominated the market in 2022 with a share of 66.41% primarily driven by the rising incidence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders. This segment is also anticipated to maintain the highest CAGR over the forecast period due to the increasing awareness about the importance of regular health checkups. Blood collection products play a crucial role in diagnostics as they are predominantly used to obtain blood samples for identifying infections caused by pathogenic microorganisms and detecting abnormalities in various blood components.
The increasing prevalence of infectious diseases has led to a growing need for blood collection and sample preparation. According to the WHO, around 10.6 million people worldwide were affected by tuberculosis in 2021, including 6 million men, 3.4 million women, and 1.2 million children. In addition, the same source reported that 1.6 million individuals died due to tuberculosis in the same year. Tuberculosis stands as the 13th leading cause of global mortality and is the second-most significant infectious cause of death after COVID-19.
Thus, the rising incidence of infectious diseases is expected to drive the demand for diagnostic solutions, thereby fueling market growth during the forecast period.Furthermore, the number of individuals affected by sickle cell anemia has substantially increased the demand for blood and its components. The American Society of Hematology estimates that approximately 70,000 to 100,000 individuals in the U.S. are impacted by sickle cell disease. Therefore, there is a significant need for transfusions to manage this condition. This escalating demand for blood and its components globally is expected to drive market growth significantly.
Based on methods, the market is divided into manual blood collection and automated blood collection. The Manual blood collection segment held the largest market share of 76.80% ofthe overall revenue in 2022. This can be attributed to the extensive usage of this method by hospitals, individual clinical laboratories, and pathology laboratories. It is the most used method in the market.A recent initiative in the field of manual blood collection involves the development and adoption of advanced needle technologies. These technologies aim to improve the overall collection process by enhancing patient comfort, reducing the risk of complications, and ensuring efficient sample collection. Furthermore, there are ongoing efforts to integrate digital technologies into the manual collection.
This includes the development of devices that provide real-time feedback on the quality and quantity of samples collected, ensuring accurate and efficient sample collection. These initiatives in manual collection aim to improve the overall patient experience, enhance safety for healthcare professionals, and optimize sample collection processes, ultimately leading to more effective and efficient collection procedures. The automated blood collection segment is projected to have the highest growth rateduring the forecast period owing to the growing demand for safe and secure procedures and the adoption of enhanced collection products. For instance, in May 2022, Vitestro unveiled an innovative autonomous blood-drawing device. To obtain accurate and secure blood collection, this new product combines AI and ultrasound-guided 3D reconstruction with robotic needle insertion.
Based on end-uses, the market is divided into hospitals, diagnostic centers, blood banks, emergency departments, and others. hospitals accounted for the largest market share of 36.57% in 2022. The global increase in the number of chronic diseases, as well as the growing amount of diagnostic and screening tests, are expected to boost the segment's growth. The hospitals segment is influenced by factors, such as advancements in collection technologies, increasing demand for blood products, evolving regulatory guidelines, and the overall healthcare landscape.
As hospitals continue to play a critical role in patient care, the demand for efficient and reliable collection services is expected to remain significant.Diagnostic centers are expected to gain a major revenue share by 2030 as a result of the accessibility of advanced technology that allows for faster results. The World Health Organization has reported a notable rise in the prevalence of tropical diseases, such as malaria, chikungunya, dengue, and yellow fever. This increase in incidence has led to a growing demand for diagnostic devices to detect these diseases.
North America dominated the market in 2022 with the largest revenue share of 40.3%, which can be attributed to the growing demand for collection products. The key factors that drive the market's expansion are a rise in the number of road accidents and the increasing incidence of chronic diseases. Moreover, with the COVID-19 impact on the U.S., the region anticipates strong market growth during the forecast period.According to the American National Red Cross's latest update estimates for 2022, nearly 29,000 units of red blood cells are required every day, and nearly 16 million blood components are transfused in the U.S. annually.
Furthermore, as per the Globocan 2020 report, Canada had 8,506 cases of Non-Hodgkin lymphoma in 2020, with 313 deaths. The rise in non-Hodgkin lymphoma cases is anticipated to drive the market demand. Following North America, Europe emerged as the second-highest revenue contributor with a CAGR of 7.8% projected during the forecast period. The growth in this region can be attributed to several factors, including the rising number of blood donation initiatives and the presence of major market players.
For instance, according to the European Blood Alliance, NHS Blood, and Transplant collects approximately 1.7 million voluntary donations, while the Scottish National Blood Transfusion Service handles around 250,000 donations annually from a donor base of 140,000. These statistics highlight the significant blood collection activities in the region, further propelling market expansion.The Asia Pacific region is expected to have a substantial growth rate over the forecast period. Mainly due to the rising disposable income and an increasing incidence of sepsis and HAI. Moreover, the strong presence of key players in this region is expected to contribute to itsgrowth over the forecast period.
Major companies in the industry are implementing various strategic initiatives. These include the development of new products, collaborations with other organizations, and expanding their presence in different regions to gain maximum market share. For instance, in February 2022, Abacus dx introduced a new addition to Streck's blood collection tube portfolio known as RNA Complete BCT. This innovative collection tube is designed to maintain the concentration of cell-free RNA during the blood draw process while minimizing the release of extracellular vesicles, including exosomes, from blood cells. This advancement aims to optimize the collection and preservation of RNA samples for various applications. In February 2022, BD announced the launch of its UltraSafe Plus 2.25 mL, a novel needle guard solution, which enhances drug delivery as well as other biologic solutions. Some of the key players in the global blood collection market include:
NIPRO Medical Corp.
FL Medical s.r.l.
Greiner Holding AG
Market size value in 2023
USD 11.42 billion
Revenue forecast in 2030
USD 19.86 billion
CAGR of 8.2% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD million/billion and CAGR from 2023 to 2030
Revenue forecast, company share, competitive landscape, growth factors and trends
Collection site, application, method, end-use, region
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
U.S.; Canada; UK; Germany; France; Italy; Spain; Sweden; Norway; Denmark; Russia; Japan; China; India; Australia; Thailand; South Korea; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Abbott Laboratories; NIPRO Medical Corp.; BD; Terumo Corp.; Medtronic Plc; Qiagen; FL Medical s.r.l.; Greiner Holding AG; Haemonetics Corp; Sarstedt AG & Co.
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the blood collection market report based on collection site, application, method, end-use, and region:
Collection Site Outlook (Revenue, USD Million, 2018 - 2030)
Needles and Syringes
Winged Blood Collection Sets
Standard Hypodermic Needles
Other Blood Collection Needles
Blood Collection Tubes
Application Outlook (Revenue, USD Million, 2018 - 2030)
Method Outlook (Revenue, USD Million, 2018 - 2030)
Manual Blood Collection
Automated Blood Collection
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
b. The diagnostics segment held the largest blood collection market share with a market share of 63.4%, owing to the rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases, coupled with growing awareness about regular health checkups.
b. Some of the major players operating in the blood collection market include Terumo Corp., Abbott Laboratories, Medtronic, Becton, Dickinson and Company, Qiagen N.V., NIPRO Medical Corp., Greiner Holding AG, Sarstedt AG & Co., Haemonetics Corp. and FL MEDICAL s.r.l.
b. The increasing prevalence of infectious diseases, the mounting number of accident & trauma cases, and non-communicable diseases are the key factors contributing towards market growth.
b. The global blood collection market size was estimated at USD 10.64 billion in 2022 and is expected to reach USD 11.42 billion in 2023.
b. The global blood collection market is expected to grow at a compound annual growth rate of 8.2% from 2023 to 2030 to reach USD 19.86 billion by 2030.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."